| LUMO Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the LUMO market cap history going back to 3/19/2020:
Also see: LUMO Shares Outstanding History and LUMO YTD Return |
As of 11/5/2024 NewLink Genetics has a market cap of 37.97 million. Investors often follow the LUMO market cap history to compare the size of the company over time.
This page shows LUMO market capitalization trends over time, with 21 market cap datapoints presented, dating back to 3/19/2020.

| LUMO Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the LUMO market cap history going back to 3/19/2020:
Also see: LUMO Shares Outstanding History and LUMO YTD Return |
| LUMO Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||
LUMO Historical Market Cap: +0.95% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||
| LUMO Stock Price Chart |
| About Lumos Pharma Inc |
| Lumos Pharma, Inc. is a clinical-stage biopharmaceutical company. Co. is engaged in advancing its clinical program and focused on identifying, acquiring, developing, and commercializing products and new therapies for people with rare diseases. Its pipeline is focused on the development of an orally administered small molecule, LUM-201, which is a growth hormone (GH) secretagogue, also called ibutamoren, for rare endocrine disorders that require injectable recombinant human growth hormone (rhGH). LUM-201 is a tablet formulation that is intended to be administered once daily. We show 21 historical shares outstanding datapoints in our LUMO shares outstanding history coverage, used to compute LUMO market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing LUMO market cap history over the course of time is important for investors interested in comparing LUMO's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of LUMO versus a peer is one thing; comparing LUMO market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like LUMO can fluctuate over the course of history. With this page we aim to empower investors researching LUMO by allowing them to research the LUMO market cap history. |
| LUMO Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| LUMO Share Performance |
| Market Cap Peers |
| NewLink Genetics (LUMO) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
LUNG Market Cap History LVGO Market Cap History LXEO Market Cap History LXRX Market Cap History LYEL Market Cap History LYRA Market Cap History MACK Market Cap History MASI Market Cap History MBIO Market Cap History MBOT Market Cap History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.